|
MARK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.718400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.050500E-02 |
| Normal-vs-Stage2 |
6.734400E-01 |
| Normal-vs-Stage3 |
3.248000E-01 |
| Normal-vs-Stage4 |
5.667600E-02 |
| Stage1-vs-Stage2 |
4.281000E-01 |
| Stage1-vs-Stage3 |
3.717000E-03 |
| Stage1-vs-Stage4 |
2.548100E-02 |
| Stage2-vs-Stage3 |
3.416800E-01 |
| Stage2-vs-Stage4 |
1.164970E-01 |
| Stage3-vs-Stage4 |
3.502800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.145800E-02 |
| Normal-vs-AfricanAmerican |
8.867900E-02 |
| Normal-vs-Asian |
4.087200E-01 |
| Caucasian-vs-AfricanAmerican |
7.648400E-01 |
| Caucasian-vs-Asian |
9.592000E-01 |
| AfricanAmerican-vs-Asian |
8.740800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.894100E-02 |
| Normal-vs-Female |
1.433020E-01 |
| Male-vs-Female |
8.186200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.988600E-01 |
| Normal-vs-Extreme_Weight |
1.074980E-01 |
| Normal-vs-Obese |
8.951900E-02 |
| Normal-vs-Extreme_Obese |
7.186400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.390600E-01 |
| Normal_Weight-vs-Obese |
5.551800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.287200E-01 |
| Extreme_Weight-vs-Obese |
8.835200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.225600E-01 |
| Obese-vs-Extreme_Obese |
5.517400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.578300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.040600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.662600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.487600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.613600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.257820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.654500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.432300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.233800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.772750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.78103999999291E-05 |
| Normal-VS-Type2 PRCC |
2.660500E-03 |
| Normal-VS-KIRP CIMP |
8.505800E-01 |
| Normal-VS-Unclassified PRCC |
7.406600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.33066907387547E-16 |
| Type1 PRCC-VS-KIRP CIMP |
7.515900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.160400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.839600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.594030E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.346800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.779000E-01 |
| Normal-vs-N1 |
9.452800E-01 |
| Normal-vs-N2 |
1.758000E-03 |
| N0-vs-N1 |
7.848400E-01 |
| N0-vs-N2 |
4.839700E-02 |
| N1-vs-N2 |
8.324400E-03 |
|
|
